XML 240 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule II - Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Schedule II - Condensed Financial Information of Registrant
 
December 31,
2019
 
December 31,
2018
Assets
 
 
 
Investment in subsidiaries, at equity
$
1,534,367

 
$
1,599,486

Fixed maturities available for sale, at fair value
85,263

 
78,076

Short-term investments
63,992

 
76,347

Investment in unconsolidated subsidiaries
915

 
875

Cash and cash equivalents
65,956

 
25,757

Other assets
40,640

 
45,683

Total Assets
$
1,791,133

 
$
1,826,224

Liabilities and Shareholders’ Equity
 
 
 
Liabilities:
 
 
 
Due to subsidiaries
$
9,899

 
$
4,067

Dividends payable
16,676

 
43,446

Other liabilities
4,268

 
6,823

Debt less debt issuance costs
248,377

 
248,886

Total Liabilities
279,220

 
303,222

Shareholders’ Equity:
 
 
 
Common stock
631

 
630

Other shareholders’ equity, including unrealized gains (losses) on securities of subsidiaries
1,511,282

 
1,522,372

Total Shareholders’ Equity
1,511,913

 
1,523,002

Total Liabilities and Shareholders’ Equity
$
1,791,133

 
$
1,826,224

 
Year Ended December 31
 
2019
 
2018
 
2017
Revenues
 
 
 
 
 
Net investment income
$
2,694

 
$
3,495

 
$
7,646

Equity in earnings (loss) of unconsolidated subsidiaries
40

 
(325
)
 
(137
)
Net realized investment gains (losses)
19

 
(789
)
 
(8,606
)
Other income (loss)
795

 
977

 
921

Total revenues
3,548

 
3,358

 
(176
)
Expenses
 
 
 
 
 
Interest expense
14,074

 
14,844

 
16,440

Other expenses
16,653

 
17,092

 
26,351

Total expenses
30,727

 
31,936

 
42,791

Income (loss) before income tax expense (benefit) and equity in net income (loss) of consolidated subsidiaries
(27,179
)
 
(28,578
)
 
(42,967
)
Income tax expense (benefit)
(28,455
)
 
(7,142
)
 
(13,293
)
Income (loss) before equity in net income (loss) of consolidated subsidiaries
1,276

 
(21,436
)
 
(29,674
)
Equity in net income (loss) of consolidated subsidiaries
(272
)
 
68,493

 
136,938

Net income
1,004

 
47,057

 
107,264

Other comprehensive income (loss)
53,866

 
(35,238
)
 
(2,488
)
Comprehensive income
$
54,870

 
$
11,819

 
$
104,776


 
Year Ended December 31
 
2019
 
2018
 
2017
Net cash provided (used) by operating activities
$
20,055

 
$
27,981

 
$
67,779

Investing activities
 
 
 
 
 
Proceeds from sales or maturities of:
 
 
 
 
 
Fixed maturities, available for sale
27,974

 
169,822

 
295,035

Net decrease (increase) in short-term investments
12,603

 
194,035

 
11,811

Dividends from subsidiaries
52,499

 
29,395

 
99,694

Unsettled security transactions, net of change

 

 
1,100

Funds (advanced) repaid for Lloyd's FAL deposit
(4,894
)
 
(21,576
)
 
(25,449
)
Funds (advanced) repaid under Syndicate Credit Agreement
30,296

 
(11,232
)
 
(6,883
)
Funds (advanced) repaid under a business investment line of credit

 

 
(4,066
)
Other
(936
)
 
330

 
(2,276
)
Net cash provided (used) by investing activities
117,542

 
360,774

 
368,966

Financing activities
 
 
 
 
 
Borrowings (repayments) under Revolving Credit Agreement

 
(123,000
)
 
(77,000
)
Subsidiary payments for common shares and share-based compensation awarded to subsidiary employees
344

 
1,154

 
12,030

Dividends to shareholders
(93,204
)
 
(316,476
)
 
(315,228
)
Other
(4,538
)
 
(5,685
)
 
(6,868
)
Net cash provided (used) by financing activities
(97,398
)
 
(444,007
)
 
(387,066
)
Increase (decrease) in cash and cash equivalents
40,199

 
(55,252
)
 
49,679

Cash and cash equivalents at beginning of period
25,757

 
81,009

 
31,330

Cash and cash equivalents at end of period
$
65,956

 
$
25,757

 
$
81,009

 
 
 
 
 
 
Supplemental disclosure of cash flow information:
 
 
 
 
 
Cash paid during the year for income taxes, net of refunds
$
2,053

 
$
4,966

 
$
17,193

Cash paid during the year for interest
$
13,699

 
$
14,777

 
$
15,892

 
 
 
 
 
 
Significant non-cash transactions:
 
 
 
 
 
Dividends declared and not yet paid
$
16,676

 
$
43,446

 
$
267,292

Securities transferred at fair value as dividends from subsidiaries
$
34,897

 
$
98,292

 
$
190,709


Basis of Presentation
The registrant-only financial statements should be read in conjunction with ProAssurance Corporation’s Consolidated Financial Statements and Notes thereto.
At December 31, 2019 and 2018, PRA investment in subsidiaries is stated at the initial consolidation value plus equity in the undistributed earnings of subsidiaries since the date of acquisition.
ProAssurance Corporation has a management agreement with several of its insurance subsidiaries whereby ProAssurance Corporation charges the subsidiaries a management fee for various management services provided to the subsidiary. Under the arrangement, the expenses associated with such services remain as expenses of ProAssurance Corporation and the management fee charged is reported as an offset to ProAssurance Corporation expenses.